Excited to share the first article from our lab @NatImmunol https://t.co/BfIsdt3oG7 Kudos to Drs. Abraham and Samaniego-Castruita for leading the studies. This work wouldn’t be possible without our amazing colleagues @NU_CDB, @immunology_nu, @LurieCancer, @NUFeinbergMed 1/n 🧵
📢 Call for papers! #BMCCancer welcomes submissions to its new Collection on 'New breakthroughs and future directions in the treatment of hematological malignancies' guest Edited by @ajayabrams and @eskazanae To find out more visit: https://t.co/ZXW6GNH8w9
📢 I and @ajayabrams are guest editing a collection on 'New breakthroughs and future directions in the treatment of hematological malignancies' to be published in #BMCCancer@BMC_series
we welcome your valuable submissions! 🤓
👉 https://t.co/uCwmN34kt8
Goldman E-Conference Janet Rowley Prize ceremony on now! Rob Welner presenting this prestigious iCMLf prize to Ravi Bhatia. Congratulations Ravi! #ESHCML2020#ESHConferences#CML
Should we vaccinate now? @StevenSalzberg1@Forbes
1) To be clear: No one is recommending skipping phase 3 trials. Those must be completed. Question is should a parallel pathway be available to people willing to take the risk & volunteer for early access https://t.co/WQG48gG0Ih
In the 1980s, Dr. Hal Broxmeyer and his lab proved umbilical cord blood—which had routinely been discarded after birth—could be used a source of hematopoietic stem cells to treat disease. https://t.co/BEYzdGQxk2